Table 5.
Influence of various covariates and genotypes on dermatological adversities among symptomatic exposed compared with asymptomatic exposed group.
| Characters | Category | Exposed SYMP | Exposed ASYMP | OR (95% CI) |
|---|---|---|---|---|
| (N = 38) n (%) | (N = 108) n (%) | |||
| Sex | Males | 20 (52.6) | 59 (54.6) | 1 |
| Females | 18 (47.4) | 49 (45.4) | 1.08 (0.517–2.273) | |
|
| ||||
| Age (years) | ≤35 | 20 (52.6) | 61 (56.5) | 1 |
| >35 | 18 (47.4) | 47 (43.5) | 1.17 (0.556–2.453 | |
|
| ||||
| Smoking | Never | 30 (79) | 88 (81.5) | 1 |
| Current/past | 8 (21) | 20 (18.5) | 1.17 (0.468–2.94) | |
|
| ||||
| Duration of | ≤20 | 19 (50) | 62 (57.4) | 1 |
| residence (years) | >20 | 19 (50) | 46 (42.6) | 1.35 (0.642–2.83) |
|
| ||||
| GSTT1 | Wild | 27 (71) | 85 (78.7) | 1 |
| Null | 11 (29) | 23 (21.3) | 1.51 (0.651–3.484) | |
|
| ||||
| GSTM1 | Wild | 24 (63.2) | 87 (80.6) | 1 |
| Null | 14 (36.8) | 21 (19.4) | 2.42 (1.071–5.451)∗ | |
|
| ||||
| NQO1 | Wild (C/C) | 16 (44.4) | 38 (36.2) | 1 |
| Mutant (C/T + T/T) | 20 (55.6) | 67 (63.8) | 0.71 (0.329–1.529) | |
|
| ||||
| hOGG1 | Wild (C/C) | 13 (34.2) | 56 (51.8) | 1 |
| Mutant (C/G + G/G) | 25 (65.8) | 52 (48.2) | 2.07 (0.96–4.469) | |
SYMP: symptomatic, ASYMP: asymptomatic, OR: odds ratio, CI: confidence interval; ∗ P < 0.05.